Table of Contents
1 Industry Outlook 10
1.1 Industry Overview 10
1.2 Patient demographics 11
1.3 Healthcare Spending in the US 14
1.4 Definition: Cardiology Diagnostics 14
1.5 Why cardiovascular diagnostics? 14
1.6 Industry Trends 15
2 Report Outline 15
2.1 Report Scope 15
2.2 Report Summary 16
2.3 Research Methodology 17
2.4 Report Assumptions 17
3 Market Snapshot 18
3.1 Total Addressable Market (TAM) 18
3.2 Segmented Addressable Market (SAM) 20
3.3 Porter 5 (Five) Forces 22
4 Market Dynamics 23
4.1.1 Drivers 24
4.1.1.1 Increasing prevalence of cardiovascular diseases 24
4.1.1.2 Increasing geriatric population 25
4.1.1.3 Growing acceptance for minimally invasive endovascular surgeries 25
4.1.1.4 Increasing awareness towards point of care diagnostics in developing countries 25
4.1.1.1 Increase in healthcare spending 25
4.1.2 Restraints 26
4.1.2.1 High cost in installation and upgradation 26
4.1.2.2 Stringent regulations for approval 26
4.1.2.3 Intense competition among vendors 26
4.1.2.4 Lack of skilled healthcare professionals 27
4.1.2.5 Availability of alternative treatment procedure 27
4.1.3 Opportunities 27
4.1.3.1 Increase in demand for cardiac diagnostic imaging 27
4.1.3.2 Emergence of mHealth for improved outcome 27
4.1.3.3 Market expansion opportunities in emerging nations 28
4.1.3.4 Increasing number of insurance providers 28
4.1.4 DRO - Impact Analysis 29
4.1.5 Key Stakeholders 30
5 Product Types: Market Size & Analysis 31
5.1 Overview 31
5.2 ECG 34
5.2.1 Overview 34
5.3 Cardiac Imaging 35
5.3.1 Overview 35
5.4 Cardiac POC 36
5.4.1 Overview 36
5.5 Contrast Agents 38
5.5.1 Overview 38
6 End-user: Market Size and Analysis 40
6.1 Overview 40
6.2 Hospitals 41
6.3 Ambulatory Surgical Center 42
6.3.1 ASCs in the Americas 42
6.3.1.1 US 42
6.3.1.2 Canada 42
6.3.1.3 Mexico 43
6.3.2 ASCs in the EMEA Region 43
6.3.2.1 France 43
6.3.2.2 UK 43
6.3.2.3 Israel 43
6.3.2.4 Africa 43
6.3.3 ASCs in the APAC Region 43
6.3.3.1 Australia 43
6.3.3.2 India 43
6.3.3.3 China 43
6.4 Cardiac Centers 44
7 Regions: Market Size & Analysis 44
7.1 Overview 45
7.2 North America 46
7.2.1 Market Overview 46
7.3 Europe 47
7.3.1 Market Overview 47
7.4 APAC 49
7.4.1 Market Overview 49
7.4.2 Japan 50
7.4.3 China 50
7.4.4 India 50
7.5 Rest of the World 51
7.5.1 Market Overview 51
8 Competitive Landscape 54
8.1 Competitor Comparison Analysis 54
9 Vendor Profiles 56
9.1 Abbott Laboratories 56
9.1.1.1 Overview 56
9.1.2 Overview 56
9.1.3 Business Unit 59
9.1.4 Geographic Presence 60
9.1.5 Business Focus 61
9.1.6 SWOT Analysis 62
9.1.7 Business Strategy 62
9.2 F.Hoffmann-La Roche Ltd 63
9.2.1 Overview 63
9.2.2 Business Unit 66
9.2.3 Geographic Presence 67
9.2.4 Business Focus 68
9.2.5 SWOT Analysis 68
9.2.6 Business Strategy 69
9.3 GE Healthcare 70
9.3.1.1 Overview 70
9.3.1.2 Business unit 73
9.3.1.3 Business focus 74
9.3.1.4 SWOT analysis 74
9.4 Philips Healthcare 76
9.4.1.1 Overview 76
9.4.1.2 Business unit 80
9.4.1.3 Business focus 81
9.4.1.4 SWOT analysis 82
9.4.1.5 Business strategies 83
9.5 Siemens Healthineers Inc. (Siemens AG) 83
9.5.1 Overview 83
9.5.2 Business Units 86
9.5.3 Geographic Presence 88
9.5.4 Business Focus 88
9.5.5 SWOT Analysis 89
9.5.6 Business Strategy 89
10 Companies to watch for 90
10.1 Medtronic Plc 90
10.1.1 Key Highlights 90
10.1.2 Business Strategies 90
10.2 Hill-Rom Holdings' Inc 91
10.2.1 Overview 91
10.2.2 Key Highlights 92
10.2.3 Business Strategies 92
10.3 Qiagen N.V. 93
10.3.1 Overview 93
10.3.2 Key Highlights 93
10.3.3 Business Strategies 94
10.4 Boston Scientific Corp 97
10.4.1 Key Highlights 97
10.4.2 Business Strategies 97
10.4.3 Mortara Instruments 99
10.4.4 Key Highlights 99
10.4.5 Business Strategies 100
10.5 Instrumentation Laboratory (a Werfen company) 101
10.5.1 Overview 101
10.6 Becton Dickinson and Company 102
10.6.1 Overview 102
Annexure 104
> Acronyms 104